Home | Contact Us | Sitemap
   
About Us
Research Priorities
Emerging Technologies
BioSciences
eBusiness
Insight Building Events
Research Publications
Insights for Induustry
Honors & Awards
Student Fellowships
Links and Resources
Industry Partners

Industry Partners

The Mack Center acknowledges the ongoing support of our industry partners, who provide input to our research and conference agenda, and help us stay current with cutting edge trends.  Our partners have access to Wharton faculty, attend events especially designed for our partners, and gain early access to our faculty research.  Mack Center partners exchange insights on topics of mutual interest and concern with peer executives in other industries, and benefit from the "catalyst effect" that comes from being exposed to a variety of fresh management approaches and strategies, in the field of technological innovation.

 

  • AstraZeneca
  • Biomedical Research & Education Foundation
  • Cisco Systems
  • Deloitte Life Sciences
  • EMS Technologies
  • GlaxoSmithKline
  • Hitachi Chemical Research Center
  • IBM
  • Johnson & Johnson
  • National Security Agency
  • Olympus America
  • Pfizer
  • Procter and Gamble
 

Olympus USA - Welcoming our Newest Partner

The Mack Center is pleased to welcome Olympus America as the newest member in our industry partner group.  Mark Gumz, President and Chief Operating Officer, and Mark Van De Voorde, Vice President, Corporate Planning and Strategy; are our partner representatives to the program. 

Olympus is well known for its digital cameras and optical technologies; the company is also a world leader in research and clinical microscopes and diagnostic testing.  Olympus created the first camera that lets doctors look inside the human body, and we continue to introduce life-altering imaging technologies for healthcare professionals. 

For more information on Olympus' growing and impressive line of technological innovations, visit their website: http://www.olympusamerica.com/

AstraZeneca, GlaxoSmithKline, EMS Technologies

The Mack Center includes a biotech and pharmaceutical interest group, which enables us to explore critical issues facing firms involved in emerging medical and life science technologies.  Recent pharmaceutical partners include AstraZeneca and GlaxoSmithKline.  All of our biotech/pharma partner firms are "Mack Center Partners" involved in both the BioSciences Crossroads Initiative and Emerging Technologies Management Research Program in the Mack Center. 

AstraZeneca is a $26.5 billion global pharmaceutical company with corporate offices in London, R&D sites in Sweden, the U.K. and U.S.; and 27 manufacturing sites in 19 countries. The company's products are concentrated in six key areas: cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory illnesses.  AstraZeneca's global research organization includes more than 12,000 people working at 16 major research centers.  The company's research teams work across national boundaries to develop new biopharmaceutical medicines. 


GlaxoSmithKline, headquartered in the U.K. with operations based in the U.S., represents approximately 7% of the world's pharmaceutical market.  In addition to a broad range of prescription pharmaceuticals, the company markets over 25 vaccines--one quarter of the world's vaccines--to protect against a wide variety of illnesses ranging from hepatitis A and B to typhoid and influenza; more than 1300 scientists are dedicated to developing new vaccines.  Every second, GlaxoSmithKline distributes more than 35 doses of vaccine and accounts for 1,100 prescriptions. GSK's research teams are researching the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria.  More than 200 million people worldwide use a GSK brand toothbrush or toothpaste.


EMS Technologies

EMS Technologies, a leader in wireless technologies for civilian, aerospace and military applications, is one of the newest members of the Emerging Technologies Management Research Program.  EMS is a international innovator in the design and manufacture of wireless, satellite and defense solutions, particularly in the broadband and mobile information markets.  CEO Paul Domorski has led this $250 million company through a period of extraordinary growth and technological innovation. 

The company develops innovative technologies using wireless innovations, ranging from in-flight communications to sophisticated systems for defense and military applications.

In 2007, EMS was named one of Forbes' 200 best companies.  EMS has been on the Deloitte "Fast 50" technology companies in George three consecutive years.  In 2007, Paul Domorski was named 2007 Atlanta Telecom Professional of the Year.
Becoming an Industry Partner in the Mack Center
To help guide our research and make it relevant and valuable to the companies who are facing the challenges we're studying, we have enlisted the involvement and support of a group of leading corporations representing a cross-section of many industries.

Our industry partner group functions as a high level corporate learning network, where research sponsored by the Mack Center can be made available to senior decision makers in large organizations that are facing the challenges and opportunities posed by technological innovation. 

When a new partner joints the Mack Center we begin by arranging a get acquainted meeting so our faculty understands the company's critical issues and interests, so we can incorporate these into our research and conference planning.

Becoming An Industry Partner.
Participation is by invitation of our core faculty. Partner firms can participate in any or all of our   research programs: the Emerging Technologies Management Research Program, BioSciences Crossroads Initiative and Wharton eBusiness Initiative (WeBI). Most firms become "Mack Center Partners" which includes participation in the ET Program and BioSciences initiative.
Targeted Research Projects.
The Mack Center also works with individual companies to sponsor larger "targeted research projects" on management research topics that offer generalizable research value. These projects are designed by a team of senior faculty in collaboration with the company sponsor, which participates actively in the project.  We have worked with such companies as Charles Schwab, Infosys Technologies and most recently, Cisco Systems on targeted research designed to provide insights into various aspects of innovation.
A Corporate Learning Network.   

Our industry partners participate in a high level corporate learning network that involves an active program of research by Wharton faculty and colleagues at other leading business schools, conference presentations by best practice firms in many industries, publication of reports on topics of interest to senior decision makers, and a variety of special initiatives. One of the key aspects of this network is the opportunity to discuss topics of mutual interest with peer managers from other industries, and with Wharton faculty experts in many fields.

Representatives from our partner firms are invited to industry partner events that are designed by our senior faculty on topics of interest and concern to our partner firms. We call these events "insight-building events" because our partners consistently report that the exposure to new and different ways of thinking about various business topics helps them develop new approaches in their own firms. Typically, four to five events are sponsored each year. Partner firms typically send from one to a half dozen representatives to a particular event (or more, if there is special interest in a topic). There are no conference fees for Mack Center events.
Partner firms also receive printed reports on a variety of research topics such as "Innovation and Organic Growth," "Creating and Managing Networks of Innovation," "Value Creation and Destruction in Emerging Technologies: Lessons for the Biosciences" -- to name a few. These reports are especially useful for sharing insights from our events with executives who cannot attend a particular event in person, and are also valuable to share with colleagues who have an interest in a conference topic.
Involvement.
Each partner becomes involved for a minimum of three years, during which time the organization provides an annual funding contribution.  We are proud of the fact that our funding contributions have not been increased since the inception of our center in 1995. Most of our partners participate in more than one program, at a combined contribution that is lower than if the firm joined each program separately.
Despite maintaining our partner contributions at the same rate, increasing participation has enabled us to fund an average of 25 faculty research projects per year.
Firms that have supported the Mack Center in the past are also deserving of recognition and we express our gratitude to: Accenture, AT&T, Avaya, Bank of Montreal, Biogen, Bristol Myers, DuPont, General Motors, Hewlett Packard, Independence Blue Cross, Knight-Ridder, Reliance Industries, Sprint, 3M, ...to name a few.

Insight.

Many of our partners view our programs as a catalyst for developing fresh insights and approaches to their operational challenages and opportunities.  Some use it to help provide both middle and senior managers with valuable exposure to fresh management approaches, strategies and best practices that are being applied in other firms and industries.  If you have an interest in participating in the Mack Center as an industry partner, please contact us.

To learn more about partnering opportunities, please contact: Michael S. Tomczyk at 215-573-7722 or email: mackcenter@wharton.upenn.edu

 
A Note of Appreciation


The Mack Center wishes to acknowledge the contribution and enthusiasm of our industry partner firms, who represent a broad spectrum of industries.  Our partner firms include the distinguished organizations shown here (click on the name to learn more about each organization):

AstraZeneca

Biomedical Research   and Education Foundation (BREF)

Cisco Systems

Deloitte Consulting

EMS Technologies

GlaxoSmithKline

Hitachi Chemical
   Research Center

IBM

Johnson & Johnson

National Security     
   Agency

Olympus America Inc.

Pfizer

Procter and Gamble

These are only a few of the many organizations that have assisted the Mack Center during the past decade.  We also collaborate with other research centers, such as the Biomedical Research and Education Foundation (BREF) and Chemical Heritage Foundation.

We wish to extend our special gratitude to William and Phyllis Mack, whose generous endowment to the Mack Center has provided core support for our overall program of management research, insight-building events, and support for student education, technology-related projects and annual events.